- Telehealth Visits
- Insurance plan information
Anna Victoria Molofsky, MD, PhD
Psychiatry- Telehealth Visits
- Insurance plan information
Psychiatry Mission Bay
Anna Victoria Molofsky, MD, PhD
PsychiatryPsychiatry Mission Bay
- Telehealth Visits
- Insurance plan information
On this page
About me
Education & training
Board certification
- Psychiatry, American Board of Psychiatry/Neurology-Psychiatry
Fellowship
- Psychiatry, University of CA at San Francisco School of Med
- Neuroscience, UCSF Graduate Medical Education
Residency
- Psychiatry, University of CA at San Francisco - Psychiatry GME
Internship
- Psychiatry, University of CA at San Francisco - Psychiatry GME
Degree
- MD, University of Michigan Medical School
My expertise
Specialties
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%221411%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221411%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.